$22.84
1.13% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US45166A1025
Symbol
IDYA

IDEAYA Biosciences Inc Stock price

$22.84
+0.36 1.60% 1M
+1.46 6.83% 6M
-2.86 11.13% YTD
-14.74 39.22% 1Y
+7.92 53.08% 3Y
+11.11 94.71% 5Y
+11.65 104.11% 10Y
+11.65 104.11% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.26 1.13%
ISIN
US45166A1025
Symbol
IDYA
Industry

Key metrics

Basic
Market capitalization
$2.0b
Enterprise Value
$1.3b
Net debt
positive
Cash
$670.0m
Shares outstanding
88.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
286.0 | 143.6
EV/Sales
190.3 | 96.1
EV/FCF
negative
P/B
2.1
Financial Health
Equity Ratio
94.2%
Return on Equity
-25.9%
ROCE
-39.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$7.0m | $14.1m
EBITDA
$-382.0m | $-320.1m
EBIT
$-384.4m | $-336.4m
Net Income
$-331.3m | $-288.4m
Free Cash Flow
$-297.1m
Growth (TTM | estimate)
Revenue
-41.5% | 101.4%
EBITDA
-102.1% | 1.4%
EBIT
-100.8% | -2.9%
Net Income
-115.2% | -5.1%
Free Cash Flow
-120.7%
Margin (TTM | estimate)
Gross
-
EBITDA
-5,456.5% | -2,270.1%
EBIT
-5,491.7%
Net
-4,733.0% | -2,045.1%
Free Cash Flow
-4,244.7%
More
EPS
$-3.8
FCF per Share
$-3.4
Short interest
15.8%
Employees
131
Rev per Employee
$50.0k
Show more

Is IDEAYA Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

IDEAYA Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a IDEAYA Biosciences Inc forecast:

19x Buy
86%
3x Hold
14%

Analyst Opinions

22 Analysts have issued a IDEAYA Biosciences Inc forecast:

Buy
86%
Hold
14%

Financial data from IDEAYA Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
7 7
41% 41%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 49 49
48% 48%
703%
- Research and Development Expense - -
-
-
-382 -382
102% 102%
-5,456%
- Depreciation and Amortization 2.47 2.47
2% 2%
35%
EBIT (Operating Income) EBIT -384 -384
101% 101%
-5,492%
Net Profit -331 -331
115% 115%
-4,733%

In millions USD.

Don't miss a Thing! We will send you all news about IDEAYA Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IDEAYA Biosciences Inc Stock News

Positive
The Motley Fool
7 days ago
IDEAYA Biosciences (IDYA -3.52%), a precision oncology company focused on developing targeted therapies for cancer, reported its second-quarter earnings on August 5, 2025. The company did not report any revenue for the quarter.
Positive
Seeking Alpha
7 days ago
IDEAYA Biosciences' recent pipeline updates highlight promising clinical trial results, strengthening my confidence in their long-term growth potential. A robust financial position supports ongoing R&D investments and mitigates near-term cash flow risks. Key strengths include a diversified product portfolio and strong management execution, though regulatory and competitive risks remain.
Neutral
PRNewsWire
7 days ago
Phase 2/3 trial of the darovasertib and crizotinib combination in 1L HLA-A2-negative metastatic uveal melanoma (MUM) on track to report median PFS data by year-end 2025; potential to enable a U.S. accelerated approval filing First-reported median overall survival data in over 40 1L MUM patients from single-arm Phase 2 trial of the darovasertib and crizotinib combination to be provided at a medi...
More IDEAYA Biosciences Inc News

Company Profile

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Head office United States
CEO Yujiro Hata
Employees 131
Founded 2015
Website www.ideayabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today